Govt Job: for the post of Pharmacist at ECHS

Retired Armed Forces personnel till 2002 could avail medical facilities only for specific high-cost surgery/treatment for a limited number of diseases covered under the Army Group Insurance (Medical Branch Scheme) (AGI(MBS)) and Armed Forces Group Insurance Scheme (Management Information System) (AFGIS (MIS)) schemes.

These medicare schemes could provide some relief to the ESM, but it was not a comprehensive scheme as compared to and available for other Central Government Employees.

ECHS invites applications to engage the following non-medical staff on a contractual basis at ECHS Polyclinics Jalgaon and Buldana for a period of one year for ESM and 11 months for civil candidates.

Post: Pharmacist

No of posts: 01 (Jalgaon-1)

Minimum Qualification: B.Pharm or 10+2 with Physics, Chemistry & Biology and Diploma in Pharmacy and registered as pharmacist under the Pharmacy Act 1948

Work Experience: Min three years
Salary Rs. : Rs 28100/-

Last Date of Receipt of Application as per requisite format along with self-attested photocopies of testimonials in support of educational qualification, work experience, and original medical fitness certificate from SEMO/CMO will be submitted to OIC ECHS Cell, Stn HQ Bhusawal PO: Ordnance Factory Bhusawal, PIN 425203 through Registered/Speed Post by 12 Aug 2022 in duplicate. Any application received after August 12, 2022, will not be accepted.

Interview Date, Timing & Venue The candidate must reach Station Headquarters Bhusawal at 0800 hrs on August 30, 2022, for the interview to be held between 1000 hrs and 1400 hrs.

Candidates must bring all the original Certificates/Mark sheet/ Degree of MBBS/Dental/ Matric/10+2 & Graduation/ Post Graduation/Diploma/Course/Work Experience and Discharge Book /PPO/Service Record and 02 PP Size color photographs at the time of interview. No TA/DA is admissible.

Only candidates meeting the Qualitative Requirement may apply.

Related Posts

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn bio sciences Inc, a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Queen’s University to develop and manufacture AAV9-GM2, a gene therapy…

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

Cellution Biologics Inc, a biologics company focused on developing, manufacturing and commercializing advanced human tissue-based products, announced the completion of its acquisition of the SimpliDerm hydrated human acellular dermal matrix…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

US appeals court sides with Sun Pharma in Lipitor antitrust case

US appeals court sides with Sun Pharma in Lipitor antitrust case

Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad

Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad